Protected: The VESL Wall Issue #13 is now out! This month we feature the new CCS guidelines on peripheral arterial disease and we bring you a cost-effectiveness analysis of inclisiran in the US healthcare system, and a statistical model to better predict familial hypercholesterolemia and improve the screening yield to enable earlier intervention

This content is password protected. To view it please enter your password below: